EFLAPEGRASTIM-XNST: 21 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
21
Total FAERS Reports
2 (9.5%)
Deaths Reported
7
Hospitalizations
21
As Primary/Secondary Suspect
1
Life-Threatening
Prescription
Status
FDA Application: 761148 ·
First Report: 20221201 · Latest Report: 20250613
What Are the Most Common EFLAPEGRASTIM-XNST Side Effects?
#1 Most Reported
White blood cell count increased
4 reports (19.0%)
#2 Most Reported
Leukocytosis
3 reports (14.3%)
#3 Most Reported
Thrombocytopenia
2 reports (9.5%)
All EFLAPEGRASTIM-XNST Side Effects by Frequency
No side effect data available.
Who Reports EFLAPEGRASTIM-XNST Side Effects? Age & Gender Data
Gender: 76.5% female, 23.5% male. Average age: 69.8 years. Most reports from: US. View detailed demographics →
Is EFLAPEGRASTIM-XNST Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2022 | 2 | 1 | 2 |
| 2023 | 7 | 0 | 5 |
| 2024 | 2 | 0 | 0 |
| 2025 | 2 | 1 | 0 |
What Is EFLAPEGRASTIM-XNST Used For?
| Indication | Reports |
|---|---|
| Colony stimulating factor therapy | 7 |
| Product used for unknown indication | 7 |
| Neutropenia | 6 |
Official FDA Label for EFLAPEGRASTIM-XNST
Official prescribing information from the FDA-approved drug label.